Chlorhexidine (di)gluconate locking device for central line infection prevention in intensive care unit patients: a multi-unit, pilot randomized controlled trial.
British journal of nursing (Mark Allen Publishing)（2022）
摘要
ClinicalTrials.gov Identifier NCT03309137, registered on October 13, 2017.
更多查看译文
关键词
CLABSI,Central venous catheter,Chlorhexidine gluconate,Locking solution,Prevention,Sepsis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要